๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Investigating the Mechanisms of Welwalk Robot in Restoring Motor Function of the Lower Extremities in Stroke Patients
NCT07057700Stroke, Walking Impairment
Ruijin Hospital
Not applicable
38
Shanghai
2025-07-01
Recruiting
Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
NCT07168980Mature B-cell Non-Hodgkin Lymphoma
Children's Cancer Group, China
Phase 2/3
87
Shanghai
2025-07-01
Not yet open
Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC
NCT06861894Esophageal Squamous Cell Carcinoma
Zhigang Li
Phase 2
164
Shanghai
2025-07
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Not yet open
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 1/2
33
Shanghai, Wuhan
2025-07
Not yet open
A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China
NCT07042113Atopic Dermatitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
180
Wenzhou, Shanghai
2025-07
Not yet open
A Study of QLS5133 Monotherapy in Advanced Solid Tumors
NCT07061639Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
212
Shanghai
2025-07
Not yet open
Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer
NCT07041437Advanced Breast Cancer
Fudan University
Phase 2
48
Shanghai
2025-06-30
Recruiting
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
NCT07097740AORTIC VALVE DISEASES, Mitral Valve Disease, Aortic Stenosis, Aortic Regurgitation
Mitrassist Lifesciences Limited Co., Ltd.
Not applicable
10
Shanghai
2025-06-27
Recruiting
Evidence-based Practice in the Management of Gastric Tube Placement in Children
NCT07038538Hospitalized Children, Nursing, Enteral Nutrition Therapy
Children's Hospital of Fudan University
Not applicable
2,750
Shanghai, Beijing, Chongqing, Gansu, Guangdong, Hefei, Henan, Hunan
2025-06-26
Active, closed
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
NCT06843408Chronic Graft-versus-host-disease
Incyte Corporation
Phase 1/2
32
Beijing, Chengdu, Chongoing, Guangzhou, Hangzhou, Shanghai, Tianjin, Wuhan
2025-06-25
Not yet open
Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions
NCT06994611Pancreatic Diseases
Changhai Hospital
Not applicable
148
Shanghai
2025-06-25
Not yet open
The 22G Trident Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
NCT07023562Pancreatic Diseases
Changhai Hospital
Not applicable
270
Shanghai
2025-06-25
Recruiting
A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
NCT06986785Advanced Hepatocellular Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
74
Shanghai
2025-06-24
Not yet open
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
NCT07036185Gastric/Gastroesophageal Junction Cancer, Breast Cancer, Colorectal Cancer, Non-small Cell Lung Cancer (NSCLC)
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 1
66
Shanghai
2025-06-24
Recruiting
An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
NCT06938282Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
60
Shanghai
2025-06-23
Active, closed
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT05761912Prostate Cancer, Ultrasound, Radiomics
Shanghai Minhang Central Hospital
Observational
464
Shanghai
2025-06-23
By invitation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
NCT06924697Diabetes Mellitus, Type 2, Nicotine Dependence, Cigarettes
Shanghai East Hospital
Not applicable
46
Shanghai
2025-06-21
Recruiting
Validation of the Effectiveness of the CFIR - ERIC Matching Tool in Implementation Research
NCT07184489Infusions, Intravenous, Implementation Science
Children's Hospital of Fudan University
Not applicable
394
Shanghai
2025-06-20
Recruiting
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
NCT07028086Acute Myeloid Leukemia, Myeloid Sarcoma
Ruijin Hospital
Phase 2
48
Shanghai
2025-06-20
Recruiting
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
NCT06980272Advanced Non-Small Cell Lung Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 3
420
Shanghai
2025-06-20
Not yet open
Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06994234Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai East Hospital
Not applicable
82
Shanghai
2025-06-20
Not yet open
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292Lupus Nephritis (LN), ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital
Phase 1/2
12
Shanghai
2025-06-20
Recruiting
A Study in Children With Achondroplasia
NCT07301463Achondroplasia
Abbisko Therapeutics Co, Ltd
Observational
260
Beijing, Guangzhou, Zhengzhou, Wuhan, Shanghai, Chengdu, Hangzhou
2025-06-20
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study
NCT06998706Interstitial Lung Disease (ILD)
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-19
Recruiting
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion
NCT07002476Stroke
Shanghai East Hospital
Phase 3
978
Shanghai
2025-06-19
Recruiting
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
NCT06987734Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
25
Shanghai
2025-06-19
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study
NCT06987214Bronchiectasis Adult
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-18
Active, closed
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
NCT07193615Alpha-1 Antitrypsin Deficiency (AATD)
RenJi Hospital
Phase EARLY_PHASE1
18
Shanghai
2025-06-18
Recruiting
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
NCT07026994Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Huashan Hospital
Phase 2
80
Beijing, Chengdu, Shanghai
2025-06-18
Recruiting
A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors
NCT06992713Advanced Solid Tumor
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Phase 1
36
Nanjing, Beijing, Shanghai
2025-06-18
Recruiting
Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer
NCT07824479Advanced Gastric Cancer
Ruijin Hospital
Observational
120
Shanghai
2025-06-17
Recruiting
Phase I Study of HBT-708 for Patients With Advanced Solid Tumors
NCT06993870Advanced Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
60
Shanghai
2025-06-16
Recruiting
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
NCT07025408Burn, Burn Wounds - Partial Thickness (2nd Degree)
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 2
144
Shanghai
2025-06-16
Recruiting
CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
NCT07019363Breast Cancer, Adjuvant Therapy
Fudan University
Phase 3
1,903
Shanghai
2025-06-15
Recruiting
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer๏ผšMetBio-GC
NCT07076979Gastric Cancer
Shanghai Minimally Invasive Surgery Center
Observational
250
Shanghai
2025-06-15
Recruiting
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer๏ผšMetBio-CRC
NCT07068529Colorectal Cancer
Shanghai Minimally Invasive Surgery Center
Observational
250
Shanghai
2025-06-15
Active, closed
QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors
NCT06892925Biliary Tract Tumors
Eastern Hepatobiliary Surgery Hospital
Phase 2
59
Shanghai
2025-06-14
Recruiting
Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2
NCT06920199cGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
18
Shanghai
2025-06-14
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
Alexion Pharmaceuticals, Inc.
Phase 3
36
Beijing, Shanghai
2025-06-14
Recruiting
Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial
NCT07662733Postoperative Sleep Disturbances, Chronic Post-surgical Pain
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2025-06-13
Recruiting
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
NCT07363967Solid Tumor Malignancies
Beijing StoneWise Technology Co., Ltd
Phase 1
60
Shanghai
2025-06-13
Recruiting
Biomarkers Based EArly Diagnosis of STroke Subtype Cohort๏ผˆBio-EAST๏ผ‰
NCT07003477Stroke
Shanghai East Hospital
Observational
527
Shanghai
2025-06-12
Recruiting
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT07376707CRC (Colorectal Cancer), Melanoma (Skin Cancer), HCC - Hepatocellular Carcinoma, NSCLC (Non-small Cell Lung Cancer)
Hefei TG ImmunoPharma Co., Ltd.
Phase 1
194
Shanghai
2025-06-12
Not yet open
Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
NCT07024394Neurofibromatosis 1, Plexiform Neurofibroma, NF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1/2
65
Shanghai
2025-06-12
Recruiting
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
NCT06953999Pancreatic Cancer
Akeso
Phase 3
999
Harbin, Shanghai, Hangzhou
2025-06-11
Recruiting
A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer
NCT07653893Central Nervous System (CNS) Metastases, Breast Cancer
Fudan University
Observational
60
Shanghai
2025-06-11
By invitation
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
NCT07074704Negative Symptoms in Schizophrenia, Cognition Function
Tongji University
Not applicable
60
Shanghai
2025-06-11
Recruiting
A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation
NCT06908434Solid Tumors Harboring a TP53 Y220C Mutation
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
82
Shanghai
2025-06-10
Recruiting
A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer
NCT06978114Advanced Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
46
Shanghai
2025-06-10
Recruiting
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06972641AML, MDS
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
A Dose-Expansion Trial of Intravenous HNF4ฮฑ srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394Colorectal Cancer Metastatic, Colorectal Cancer Recurrent, Colorectal Cancer Stage IV
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
20
Shanghai
2025-06-10
Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT06993844Advanced Solid Tumors, Advanced Breast Cancer
Ensem Therapeutics
Phase 1/2
233
Beijing, Fuzhou, Guangzhou, Shandong, Shanghai
2025-06-10
Recruiting
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
NCT06933069Solid Malignancies
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
55
Shanghai
2025-06-09
Active, closed
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
NCT06956235Hidradenitis Suppurativa
Merck Sharp & Dohme LLC
Phase 2
149
Guangzhou, Changsha, Changchun, Shanghai, รœrรผmqi, Hangzhou
2025-06-09
Recruiting
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
NCT07026149Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
30
Shanghai
2025-06-08
Not yet open
A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss
NCT07012746Age Related Hearing Loss, Deafness
Yilai Shu
Not applicable
60
Shanghai
2025-06-07
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Recruiting
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
NCT06907329Immunosenescence, Metabolism
Qing Su
Not applicable
126
Shanghai
2025-06-05
Recruiting
Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
NCT07272382Esophageal Neoplasms
Fudan University
Not applicable
142
Shanghai
2025-06-05
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
NCT06962839Macular Edema
Boehringer Ingelheim
Phase 2
300
Chengdu, Shanghai, Shenyang, Shijiazhuang, Taiyuan
2025-06-05
Recruiting
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus
NCT06857214Systemic Lupus Erythematosus
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
84
Shanghai
2025-06-04
Recruiting
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06954246Small Cell Lung Cancer Extensive Stage
Qilu Pharmaceutical Co., Ltd.
Phase 3
450
Shanghai
2025-06-04
Active, closed
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC๏ผ‰
NCT07076693OligoProgressive Metastatic Disease, Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2/3
97
Shanghai
2025-06-03
Recruiting
A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy
NCT06830889HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
1,450
Nanjing, Shanghai
2025-06-03
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
NCT06958536Crohn's Disease
Sanofi
Phase 2
99
Changsha, Changzhou, Guangzhou, Hangzhou, Nanchang, Shanghai, Shenyang
2025-06-03
Recruiting
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
NCT07326930Acute Lymphoblastic Leukemia ALL
The Hong Kong Polytechnic University
Observational
173
Zhengzhou, Shanghai, Shenzhen
2025-06-02
Not yet open
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
NCT06996093Breast Cancer
Fudan University
Phase 3
2,508
Shanghai
2025-06-02
Recruiting
IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
NCT07025889Gastric Cancer
Ruijin Hospital
Phase 1/2
55
Shanghai
2025-06-02
Not yet open
Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage
NCT06965556Breast Carcinoma, Patient Education, Perioperative Care, Psychological Intervention
Fudan University
Not applicable
1,138
Shanghai
2025-06-01
Recruiting
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
NCT07363291Confocal Enteroscopy, Quality Assessment System, Standardized Implementation
Shanghai Jiao Tong University School of Medicine
Observational
600
Hefei, Ningbo, Kashgar, Shanghai
2025-06-01
Not yet open
RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients
NCT06969118Atrial Fibrillation, Left Atrial Appendage Occlusion, General Anesthesia, Local Anesthesia
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-06-01
Not yet open
Pilot Evaluation of a Psychoeducation Group for Family Caregivers of Children and Adolescents With Emotional and Behavioral Disorders (CPG-CA) in China
NCT06900465Emotional and Behavioral Disorders in Children and Adolescents
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-06-01
Recruiting
Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta
NCT07092358Hereditary Ataxia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,000
Hangzhou, Shanghai
2025-06-01
Recruiting
Adjuvant Pancreatic Therapy Guided by MRD
NCT06966440Pancreatic Adenocarcinoma Resectable
Ruijin Hospital
Not applicable
856
Shanghai
2025-06-01
Recruiting
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
NCT06942234Inoperable Locally Advanced HER2-Negative Breast Cancer, Metastatic HER2-Negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1/2
180
Shanghai
2025-06-01
Recruiting
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
NCT07002177Metastatic Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Locally Advanced Breast Cancer (LABC)
Forward Pharmaceuticals Co., Ltd.
Phase 1/2
196
Shanghai
2025-06-01
Recruiting
Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in Children
NCT07351955Tic Disorders
Shanghai Children's Medical Center
Not applicable
60
Shanghai
2025-06-01
Recruiting
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
NCT05643651Kawasaki Disease, Coronary Artery Aneurysm
Children's Hospital of Fudan University
Phase 4
100
Shanghai
2025-06-01
Recruiting
Phase โ…ก Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
NCT07003022Colo-rectal Cancer, MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Fudan University
Phase 2
40
Shanghai
2025-06-01
Recruiting
Early-Onset Myopia Intervention Project
NCT07176949Myopia, Pre-myopia
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
508
Shanghai
2025-06-01
By invitation
Comparison of MIPPED-C and Surgical Necrosectomy in Pancreatic Necrosis Outcomes
NCT07097753Acute Pancreatitis (AP), Acute Pancreatitis With Infected Necrosis
Ruijin Hospital
Observational
144
Shanghai
2025-06-01
Not yet open
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment๏ผšan Open-label, Randomized, Controlled Phase II Clinical Study
NCT06946849Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital
Phase 2
76
Shanghai
2025-06-01
Not yet open
An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors
NCT06951425Solid Tumors
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase EARLY_PHASE1
24
Shanghai
2025-06-01
Not yet open
Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer
NCT06956976Rectal Cancer
Fudan University
Not applicable
1,596
Shanghai
2025-06-01
Not yet open
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
NCT06846424Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 1
24
Shanghai
2025-06-01
Recruiting
Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder
NCT07708246Autism, Intervention (Training) Condition, Social Cognition, Cognition Improvement
Children's Hospital of Fudan University
Not applicable
60
Shanghai
2025-06-01
Not yet open
UEMR Versus HSP in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in Size
NCT06996522Pedunculated Colorectal Polyp
Fudan University
Not applicable
338
Shanghai
2025-06-01
Recruiting
Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief
NCT06978816Renal Colic, Acupuncture, Ear
Gao Xiaofeng
Not applicable
116
Shanghai
2025-06-01
Recruiting
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
NCT06670495Anal Cancer
Fudan University
Observational
300
Shanghai
2025-06-01
Recruiting
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT07022964T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital
Phase 1/2
36
Beijing, Shanghai
2025-06-01
Recruiting
Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children
NCT06995911Myopia, Pre-myopia
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
80
Shanghai
2025-06-01
Not yet open
Etiological Classification-guided Individual Intervention in Primary Hypertension
NCT06941935Hypertension
Shanghai 10th People's Hospital
Not applicable
2,000
Shanghai
2025-06-01
Not yet open
The Effect of Cap-assisted Water Exchange Colonoscopy on Straight Passage of the Colonoscope Through the Sigmoid Colon, Without Loop Formation
NCT06992856Colonoscope Passage
Fudan University
Not applicable
531
Shanghai
2025-06-01
Not yet open
Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function
NCT06819202Sudden Sensorineural Hearing Loss (SSNHL), Hyperbaric Oxygen Therapy
Sun Yuting
Observational
1,309
Shanghai
2025-06-01
Recruiting
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486Androgenetic Alopecia (AGA)
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
30
Shanghai
2025-06
Recruiting
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
NCT07007078Acne Vulgaris
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
60
Shanghai
2025-06
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals
Phase 3
240
Beijing, Shanghai
2025-05-30
Not yet open
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
NCT06963502Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
762
Hangzhou, Shanghai
2025-05-30
Not yet open
hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis
NCT06853522Ulcerative Colitis (UC)
Shanghai East Hospital
Phase EARLY_PHASE1
40
Shanghai
2025-05-30
Rows per page Showing 1401–1500 of 3827
Previous 13 14 15 16 17 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=15

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.